Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Arang Pharm is a South Korean pharmaceutical company headquartered in the Pangyo Techno Valley of Seongnam. Established in 2014, the company focuses on the development, manufacturing, and commercialization of generic pharmaceutical products tailored for the domestic healthcare market. Its portfolio spans several key therapeutic areas, including respiratory, gastrointestinal, musculoskeletal, and cardiovascular diseases. Arang Pharm is recognized for its commitment to quality and its ability to maintain a stable supply of essential medications to hospitals and clinics across South Korea. The company operates as a private entity and continues to expand its product offerings through the introduction of specialty generics and improved formulations. By leveraging its strategic location in Korea's primary biotech hub, Arang Pharm maintains active collaborations for distribution and market access.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Arang Pharm.